USC Center for Vascular Care



Faculty & Staff


Curriculum Vitae - Albert E. Yellin, MD

INFORMATION

Business Address:
LAC+USC Medical Center
Department of Surgery, Room 9610
1200 North State Street
Los Angeles, California 90033

Business Phone: (323) 226-7737 FAX#: (323) 226-5815

EDUCATION

High School:
Van Nuys High School - 1954

College:
Harvard University, A.B. 1958

Medical School:
University of Southern California, M.D., 1962

Internship:
Los Angeles County+USC Medical Center, (Rotating) 1963

Residency:
Los Angeles County+USC Medical Center, (Surgery) 1965-1969

Fellowship:
Los Angeles County+USC Medical Center, (Vascular Surgery) 1969-1970

Licensure:

  • California
  • Fluoroscopy X-Ray Supervisor and Operator

Board:

  • Certified - American Board of Surgery 1970
  • Certification of Special Qualifications in General Vascular Surgery, November 18, 1983
    Recertified, October 17, 1991

MILITARY

Captain, U.S. Army Medical Corps, 1963-1965

MISCELLANEOUS

  • Advanced Trauma Life Support: Provider
  • Advanced Trauma Life Support: Instructor
  • Basic Life Support: Provider
  • Laparoscopy Certification, 1990
  • Executive Education: Management Development, USC School of Business Administration, 1996

PROFESSIONAL BACKGROUND

Academic Appointments:
  • Instructor in Surgery
    University of Southern California School of Medicine 1969-1970
  • Assistant Professor of Surgery, 1970-1975
  • Associate Professor of Surgery, 1975-1984
  • Senior Medical Research Scientist
    Center for Laser Studies, University of Southern California 1975 and 1976
  • Professor of Surgery, April 1984

Hospital Appointments:

  • Supervisor of Residents, Department of Surgery
    Los Angeles County+USC Medical Center, 1969-1970

  • Attending Surgeon, General Surgery
    Los Angeles County+USC Medical Center, 1969-1979

  • Attending Surgeon, Vascular Surgery
    Los Angeles County+USC Medical Center, 1970-1981

  • Affiliate Staff, General and Vascular Surgery
    Surgery, Hospital of the Good Samaritan, 1974 -

  • Associate Medical Director,
    Los Angeles County+USC Medical Center, 1977-1981

  • Chief of Professional Services General Hospital
    Los Angeles County+USC Medical Center, 1979-1981

  • Senior Attending Surgeon, General Surgery
    Los Angeles County+USC Medical Center, 1980 -

  • Senior Attending Surgeon, Vascular Surgery
    Los Angeles County+USC Medical Center, 1982 -

  • Chief, Peripheral Vascular Surgery
    Los Angeles County+USC Medical Center, 1982-1994

  • Attending Staff, Kenneth Norris Cancer Hospital, 1983

  • Associate Director, Department of Surgery
    Los Angeles County+USC Medical Center, 1984-1992

  • Program Director: Graduate Education in Surgery, 1990-1991

  • Attending Staff, USC University Hospital - 1991

  • Director, Vascular Surgery
    U.S.C. University Hospital, 1991-1995

  • Associate Chief of Staff 1994-
    Medical Director of Surgical Services 1994 -
    LAC+USC Medical Center & Northeast Network

Teaching Responsibilities:

Formal Lectures. Conferences. Seminars, and Patient-Oriented Teaching
  • Core Surgery Clerkship, Year III-IV, 1970 -
  • Introduction to Hospital Surgery, Year III, 1971-1973
  • Course Director, Introduction to Surgery (Lab), 1974-1979
  • Course Director, Elective in Vascular Surgery 1974-1994
  • Organ System: Year I and II (Multidisciplinary Teaching)
  • Basic Science Elective: Year III, Surgical Anatomy 1974-1975

House Officers: Intern and Resident

  • Lectures, conferences, seminars, and patient-oriented teaching
  • Weekly Vascular Surgery Conference

Postgraduate Education and Workshops

  • More than 300 lectures, conferences and workshops under auspices of Postgraduate Medicine Division or other Continuing Medical Education programs
  • Course Director: Surgical Anatomy and Surgery 1975-1976

Administrative Responsibilities:

USC School of Medicine

  • Executive Committee: Department of Surgery
  • Curriculum Committee, Year III, 1971-1976
  • Basic Science Committee, Year III, 1971-1976
  • Postgraduate Training Advisory Committee, 1971-1989
  • Health Sciences Master Plan Task Force, 1973-1974
  • Student Health Task Force, 1973-1974
  • Faculty Enrichment Task Force, 1973-1974
  • University Planning Committee Nursing Education 1973-1974
  • University Planning Committee, Relationship with Community Hospitals, 1973-1974
  • Medical Faculty Association Council, 1973-1975
  • Student Health Committee, 1973-1976
  • USC & LAC+USC Research Committee (PSA) 1974-
  • Acting Chairman 1979
  • Recommendation Committee, 1975-1980
  • Chairman: Department of Surgery Research Committee 1975-1988
  • Electives Committee, 1976-1980
  • Curriculum Committee, Year IV, 1976-1980
  • Chairman: Search Committee, Anesthesia, 1977
  • Search Committee, Director of Cancer Center, 1977
  • Search Committee, OB-GYN, 1978
  • Central Area Teaching Hospitals Council, Admissions Committee, 1981-1984
  • Co-Chairman, Future Health Care Planning Committee 1984-1988
  • Coordinating Committee, LAC+USC Professional Services Agreement, 1985-1987
  • Steering Committee, LAC+USC Professional Services Agreement, 1985-1987
  • University Hospital Planning Committee, 1986-1989
  • Joint Liaison Committee, LAC+USC Professional Service Agreement, 1977 -
  • Vice-President's Ad Hoc Advisory Committee, 1987-1988
  • Dean's Membership Committee, 1988-1992
  • Graduate Medical Education Committee, 1988
  • USC AIDS Task Force, 1988
  • Chairman: Committee to Review Department of Orthopedics, 1989
  • USC University Hospital Administrative Committee 1989-1990
  • USC-UH Clinical Access Task Force, 1990-1991
  • Task Force: Voluntary Faculty Appointments and Promotions, 1991
  • USC-UH Healthcare Consultation Center Committee, 1991-
  • USC-UH Interdisciplinary Practices Committee, 1991 -
  • Chief, Division of Vascular Surgery, 1982-1995
  • Los Angeles County+USC Medical Center Scientific Conduct Committee, 1998 -
  • Institutional Bio-Safety Committee, 2000 -

LAC+USC Medical Center

  • Utilization Review Committee, 1971-1976
  • Coordinator, Straight Surgery Intern Program 1974-1982
  • Medical Care Evaluation Committee, 1975-1976
  • Transfusion Committee, 1976-1989; 1996 -
  • Medical Records Steering Committee, 1977-1979
  • Facilities Planning Committee, 1977-1979
  • Chairman, Intensive Care Unit Directors Committee 1977-1985
  • Associate Medical Director, 1977-1981
  • Executive Medical Cabinet, 1977-1982, 1994
  • Chief of Professional Services, 1979-1981
  • Operating Room Committee, 1979-
  • Chairman 1979-1981, 1994-
  • Patient Care Fund Committee Co-Chairman, 1980-
  • Joint Practices Committee, 1979-1982
  • Associate Director, Department of Surgery, 1984-1992
  • Association of Physicians, Los Angeles County Hospital Secretary-Treasurer, 1975-1989
    Vice President, 1989 -
  • Association of County Physicians Board of Directors, 1977 -
    Vice President, 1990-1998
    President, 1999
  • Attending Staff Association Executive Committee, 1977 -
    Treasurer, 1988-2000
  • Professional Staff Association, 1970
    Treasurer, 1988-1994
  • PSA Budget & Finance Committee Chairman, 1988-1994
  • Health Research Association Treasurer, 1994-1995
    Chairman, 1995-
  • Operations Quality Council, 1995 -
  • Performance Improvement Team: Operating Rooms Chairman, 1995-1996
  • NorthEast Cluster Clinical Operations Steering Committee, 1996 -
  • LAC+USC Medical Center Space Planning Committee, 1996
  • Operating Room Labor Management Committee, 1997

Miscellaneous

  • USC Surgeons, Inc. Board of Directors, 1991
  • Insync Research, Inc., 1994 -
  • University Pathology Association Board of Directors, 2000 -

SOCIETY MEMBERSHIPS

Local:

Los Angeles Academy of Medicine
  • Los Angeles County Medical Association, 1973 -
  • Committee on Negotiations, 1978-1980
  • Alternate Councilor, 1996 -
  • President's Council, 1997 -

Los Angeles Surgical Society

  • Program Chairman, 1986-1987
  • Secretary-Treasurer, 1987-1989
  • President Elect, 1989
  • President- 1990
  • Board of Directors 1991-1995

Salerni Collegium

  • Board of Directors, 1980-
  • Membership Committee, 1993-1995

Society of Graduate Surgeons

  • Secretary-Treasurer, 1982
  • Program (Forum) Chairman, 1983-1984
  • President, 1985 and 1986
  • Board of Directors, 1977 -
  • Recorder, 1989-

State:

  • California Medical Association

  • Medical Research Association of California

  • Southern California Chapter,
    American College of Surgeons:
    • Hospital Representative, 1975-1980
    • Associate Program Chairman, 1977-1978
    • Program Chairman, 1978-1979
    • Recorder, 1979-1981
    • Secretary-Treasurer, 1982-1984
    • President-Elect, 1984
    • President, 1985
    • Board of Directors, 1986-1994
    • Committee on Applicants, 1993 -

  • Southern California Vascular Surgical Society
    • President-Elect, 1990
    • President, 1991
    • Council, 1991-1993

National & International:

  • American Association for Surgery of Trauma
  • Fellow-American College of Surgeons, Fellow
    • Governor, 1986-1992
    • Liaison Fellow, Cancer Committee, 1977-1982
    • Development Committee, 1988 -
    • Committee on Fiscal Affairs, 1988-1991
    • Fellows Leadership Society (Founding Member), 1990-
    • Committee on Trauma 1991 -
    • Executive Committee, 1993-1996
    • Chairman, Emergency Services, Prehospital
    • Committee, 1993-1997
  • Liaison, American College of Emergency Physicians, 1995-
  • National Prehospital, Trauma Life Support
    Executive Council, 1994-1996
  • American College of Surgeons: Committee on Trauma, Southern California Region
    Vice Chairman, 1980
    Chairman, 1981-1989
  • American Heart Association
  • American Surgical Association
  • American Trauma Society
  • American Venous Forum
  • The Association for Academic Surgery
  • Association of Program Directors in Surgery
  • International Association for the Surgery of Trauma and Surgical Intensive Care
  • International Society for Cardiovascular Surgery
  • The Society for Vascular Surgery
  • The American Association for Vascular Surgery
  • The Pacific Coast Surgical Association Program Committee, 1986-1989
  • Society for Clinical Vascular Surgery
  • Society of Critical Care Medicine
  • Societe’ International De Chirurgie
  • Society for Vascular Technology
  • Surgical Infection Society
  • Undersea Medical Society
  • Western Surgical Association
  • Western Vascular Society Program Committee, 1994

MISCELLANEOUS

  • National Foundation for Ileitis and Colitis:
    Los Angeles Chapter, Scientific Advisory Board, 1974-1975
  • Trauma Hospital Advisory Committee
    Los Angeles County, 1987 -
  • Consultant, NIH
    Department of Health & Human Services
  • Consultant, State of California
    Emergency Medical Services Authority
  • Editorial Board: International Vascular Surgery
  • Contributing Editor: Physician's Journal Update
  • Reviewer:
    • Journal of American Medical Assoc.
    • American Journal of Surgery
    • Surgery, Gynecology, Obstetrics
    • Archives of Surgery
    • Reviews of Infectious Diseases
    • Journal of Vascular Surgery
    • International Vascular Surgery
    • Clinical Infectious Disease
  • Venous Digest
    PharmacoEconomics
  • American Board of Surgery
    • Associate Examiner, 1975, 1982, 1984, 1987, 1990
    • Vascular Examiner, 1987, 1989

Honors:
Outstanding Teacher Award
Department of Family Practice 1987, 1992

RESEARCH INTERESTS

  • Vascular trauma and septic complications of vascular surgery
  • Surgery of trauma with emphasis on pancreatic and hepatobiliary trauma
  • Surgical control of hyperlipidemia and atherosclerosis
  • Clinical and experimental peritonitis, surgical soft tissue infections
  • Immunomodulators and sepsis
  • Prostaglandins and ischemic ulcers
  • Pharmacologic treatment of intermittent claudication
  • Venous thrombosis, hemodynamics of varicose veins

Work in Progress:

  • Clinical investigation of vascular trauma
  • Adjuvant antibiotic management of surgical infections: Four randomized prospective studies in progress involving soft tissue and intraperitoneal infections
  • Immunomodulators and sepsis syndrome
  • Pharmacology of claudication
  • Venous thrombosis and trauma

GRANTS AWARDED: PRINCIPAL INVESTIGATOR

Program on the Surgical Control of Hyperlipidemia NIH (NHBI)
6/9/78-4/30/88 $5,368,231
5/1/88-4/30/89 $ 373,433
5/1/89-4/30/92 $ 551,674

GRANTS AWARDED: PRINCIPAL OR CO-PRINCIPAL INVESTIGATOR

  • Comparison of Cefoperazone, Cefamandole, Clindamycin-Gentamicin in Peritonitis
    1981 - Pfizer $147,520

  • Comparison of Cefoxitin vs. Clindamycin-Gentamicin in Abdominal Stab Wounds
    1981 - Merck, Sharp & Dohme $219,000

  • Comparison of Sulbactam-Ampicillin vs. Clindamycin-Gentamicin in Peritonitis due to Perforated Gangrenous Appendicitis
    1982 - Pfizer $188,000

  • Efficacy of Thienamycin in Enterogenous Peritonitis
    1983 - Merck, Sharp & Dohme $35,000

  • Comparison of Sulbactam-Ampicillin vs. Moxalactam in Biliary Tract Sepsis
    1983- Pfizer $181,000

  • Comparison of Aztreonam-Clindamycin vs. Clindamycin-Gentamicin in Peritonitis
    1984- Squibb $135,000

  • Comparison of Ceftazidime-Clindamycin vs Clindamycin-Gentamicin in Penetrating Abdominal Trauma
    1984 - Glaxo $106,000

  • Comparison of Cefmetazole vs. Cefoxitin in the Prophylaxis of Infections in Elective Cholecystectomy
    1985 - Upjohn $72,000

  • Evaluation of Imipenem in the Management of Gangrenous or Perforated Appendicitis
    1986 - Merck, Sharp & Dohme $40,000

  • Effect of Ciprostene on the Healing of Ischemic Ulcers Due to Peripheral Vascular Disease
    1986- Upjohn $56,000

  • Ciprostene in Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries
    1986 - Upjohn $140,000

  • Imipenem-Cilastatin in the Management of Surgically Treated Acute Cholecystitis
    1986 - Merck, Sharp & Dohme $40,000

  • Clindamycin-Gentamicin at Two Different Doses in Management of Perforated Appendicitis
    1986 - Upjohn $102,000

  • Cefuroxime vs. Cefazolin in High Risk Cholecystectomy Patients
    1987 - Glaxo $240,000

  • Ciprofloxacin vs. Ceftazidime in Acute Cholecystitis
    1987 - Miles $40,000

  • Imipenem vs. Clindamycin-Gentamicin in Perforated Hollow Viscus
    1987 - Merck, Sharp & Dohme $100,000

  • Cefmetazole vs. Cefoxitin Abdominal Trauma
    1987 - Upjohn $193,450

  • Multicenter Controlled Study of Iloprost in Arterial Disease & Ischemic Ulcers
    1988- Berlex $155,000

  • Department of Health and Human Services Co. Invest) Hemorheologic Factors in Cerebral Ischemia
    1987-1992 $524,901

  • National Institute of Health, North American Symptomatic Carotid Endarterectomy Trial
    1988-1993 $75,000

  • Cefapime and Metronidazole vs. Gentamicin & Clindamycin in Perforated Appendicitis
    1989 - Bristol-Myers $259,000

  • Ofloxacin vs. Ceftazidime in Acute Cholecystitis
    1989 - Ortho $125,000

  • Recombinant Gamma Human Interferon in Trauma Victims and Sepsis Victims
    1989 - Genentech $150,000

  • Meropenem vs. Clindamycin-Gentamicin in Perforated Appendicitis
    1990- Stuart $210,000

  • Cefepime vs. Mezlocillin & Gentamicin in Acute Cholecystitis
    1990 - Bristol $180,000

  • Prostavasin Infusion in Treatment of Severe Peripheral Vascular Disease
    1991 - Schwarz-Pharma $85,000

  • Basic Fibroblast Growth Factor in the Treatment of Neuropathic Foot Ulcers
    1992 - Scios Nova $50,000

  • Thrombolysis and Surgery for Limb Ischemia
    1992 - Genentech $105,000

  • Ofloxacin-Flagyl vs. Clindamycin-Gentamicin in Intra-abdominal Infection
    1992 - Ortho $212,000

  • HA-IA in Septic Shock
    1992 - Centocor $30,000

  • Temafloxacin vs. Imipenem in Intra-abdominal Infection
    1992 - Abbott $110,000

  • Trospectomycin-Aztreonam vs. Clindamycin-Aztreonam in Intra-abdominal Infection
    1992 - Upjohn $260,000

  • Efficacy of Amphotericin Lipid Complex vs. Fungizone in Invasive Candidiasis
    1992 - Liposone Co. $130,000

  • Piperacillin-Tazobactam vs. Imipenem in Intra-abdominal Infection
    1992 - Lederle $393,250

  • Vasoprost Infusion in Treatment of Severe Peripheral Vascular Disease
    1993 - Schwarz-Pharma $80,000

  • Cilostazol in the Treatment of Patients with Intermittent Claudication
    1993 - Otsuka $140,000

  • Propionyl-L-Carnitine in Peripheral Arterial Disease
    1993 - Sigma-Tau $139,375

  • Urokinase vs. Operative Intervention for Acute Lower limb arterial occlusion
    1993 - Abbott $38,000

  • E-5 Monoclonal Antibody in Patients with Severe Sepsis
    1993 - Pfizer/Roerig $60,000

  • Lipo PGE1 Therapy in Patients with Ischemic Ulcers
    1994 - Alpha Therapeutic Corp $139,000 (Co-Investigator)

  • Zosyn v. Unasyn in Treatment of Intra-abdominal Infections
    1994- Lederle $92,000

  • Human GM-CSF for Prophylaxis of Postoperative Infection
    1994 - Immunex Corporation

  • L.Ofloxacin in Intraabdominal Infections
    1995 - Hoechst-Roussel

  • CP 116,517 v. Imipenem in Complicated Intra-abdominal Infections
    1995 - Pfizer- $199,550

  • CP 116,517 v. Imipenem for Prophylaxis of Infection in Elective Colorectal Surgery
    1995 - Pfizer - $36,000

  • L-NG-Methylarginine in Patients with Septic Shock
    1995 - Burrows Wellcome (Co-Investigator)

  • Atrium Graft
    1995 - Atrium (Co-Investigator)

  • RBPI21 In Complicated Intra-abdominal Infections
    1996 - Xoma $55,000 (Co-Investigator)

  • Ciprofloxacin + Metronidazole v. Piperacillin-Tazobactam in Complicated Intra-abdominal Infections
    1996 - Bayer $136,500

  • Clinafloxacin 960-013 in Intra-abdominal Infections
    1996 - Parke-Davis $116,000

  • Iloprost in Patients with Fontaine Stage II PAOD
    1996 - Berlex Laboratories $72,000

  • Piperacillin/Tazobactam+Imipenem/Cilastatin in Hospitalized Patients with Intraabdominal infections
    1997 - Wyeth-Ayerst $162,300

  • Combination IV Cipro+Metronidazole for Treatment of Complicated Intra-abdominal Infections
    1997 - Pfizer $100,000

  • Recombinant Human Activated Protein C (rhAPC) in Severe Sepsis (Sub-Investigator)
    1997 - Lilly Research Laboratories

  • L-749,345 v. Ceftriaxone+Metronidazole in Complicated Intra-abdominal Infections
    1997 - Merck Research Laboratories $404,000

  • Alatrofloxacin/Trovafloxacin Treatment of Complicated IAI
    1997 - Scirex-Pfizer $67,200

  • Ziracin v Chloramphenicol/Doxycycline in Treatment of VRE Bacteremia
    1998 - Schering-Plough $66,000

  • SCH27899 in VRE Bacteremia Patients not Treated with Chloramphenicol and/or Doxycycline
    1998 - Schering-Plough $34,000

  • Phase IIB MK-0826 v Piperacillin/Tazobactam in Hospitalized Patients with Intraabdominal Infections
    1998 - Merck Research Laboratories $280,000

  • Cubist 9803-Daptomycin: Gram Positive Bacteremia
    1999 - Advanced Biologics $50,000

  • Cubist 9804-Daptomycin Resistant Gram Positive Bacteremia
    1999 - Advanced Biologics $35,000

  • LY333328 v Vancomycin in Skin/Skin Structures Infections
    1999 - Lilly Research Laboratories $52,350

  • Venous Thromboembolism Phase III Study (Sub-Investigator)
    1999 - Astra Zeneca LP $6,000

  • Floseal Matrix Hemostatic Sealant
    1999 - Fusion Medical Technologies, Inc. (Sub-Investigator)

  • Oral Beraprost Sodium in Patients with Intermittent Claudication
    2000 - United Therapeutics $75,000

  • Roxifiban and Prevention of Ischemic Events with Moderate to Severe Peripheral Arterial Disease
    2000 - Dupont Pharmaceuticals $48,000

  • Open Label GAR-936 in Treatment of Complicated Intra-abdominal Infection (Co-Investigator)
    2000 - Wyeth-Ayerst $97,500

  • Merrem/Primaxin in the treatment of hospitalized patients with complicated skin/skin structure infections
    2000 - AstraZeneca Pharmaceutical $55,000 (Co-Investigator)

  • Phase III BMS284756 comparative study in the treatment of complicated intra-abdominal infections
    2000 - Bristol-Myers Squibb $90,000

  • Intravenous/oral Bay12-8039 for treatment of patients with complicated intra-abdominal infections
    2000 - Bayer Pharmaceutical $70,690

  • Open Label: BIR:02 Beraprost Sodium in Patients with Intermittent Claudication
    2001 - United Therapeutics $16,000

  • Etrapenem in the treatment of complicated intra-abdominal infections in hospitalized adults (STITCH)
    2001 - Merck & Co $53,575

PUBLICATIONS

  1. Yellin AE, Chaffee CB, Donovan AJ: Vascular isolation in treatment of juxtahepatic venous injuries. Arch Surg 1971;102:566?573.

  2. Donovan AJ, Yellin AE: Blunt injury to the liver: The effect of the nature of the injury and the operation on the postoperative course. J St Barnabas Medical Center 1971;8:43.

  3. Sisel RJ, Donovan AJ, Yellin AE: Experimental fecal peritonitis: Influence of barium sulfate or water soluble radiographic contrast material on survival. Arch Surg 1972;104:765?768.

  4. Yellin AE, Vecchione TR, Donovan AJ: Distal pancreatectomy for pancreatic trauma. Amer J Surg 1972;124:135?142.

  5. Donovan AJ, Michaelian MJ, Yellin AE: Anatomical hepatic lobectomy in trauma to the liver. Surgery 1973;73:833?847.

  6. Yellin AE, Newman J, Donovan AJ: Neostigmine induced hyperperistalsis: Effects on security of colonic anastomoses. Arch Surg 1973;106:779?784.

  7. Yellin AE, Shore EH: Surgical management of arterial occlusion following percutaneous femoral angiography. Surgery 1973;73:772?777.

  8. Berne CJ, Donovan AJ, White EJ, Yellin AE: Duodenal "diverticulization" for duodenal and pancreatic injury. Amer J Surg 1974;127:503?507.

  9. Yellin AE, Rosoff L: Pancreatoduodenectomy for combined pancreato?duodenal injuries. Arch Surg 1975;110:1177?1183.

  10. Yellin AE, Dwyer RM, Craig JR, Bass M, Cherlow J: Endoscopic argon ion phototherapy of bleeding gastric lesions. Arch Surg 1976;111:750?755.

  11. Dwyer RM, Yellin AE, Craig J, Cherlow J, Bass M: Gastric hemostasis by laser phototherapy in man: A preliminary report. JAMA 1976;236:1383?1384.

  12. Yellin AE: Ruptured mycotic aneurysm: A complication of parenteral drug abuse. Arch Surg 1977;112:981?986.

  13. Gaspar MR, Yellin AE: Femoral artery occlusion caused by percutaneous angiography: Mechanisms and management. Acta Chirurg Belg 1977;3:323?328.

  14. Robbins FG, Yellin AE, Lingua RW, Craig JR, Turrill F, Mikkelsen W: Splenic epidermoid cysts. Ann Surg 1978;187:231?235.

  15. Ricketts RP, Finck E, Yellin AE: Management of major arteriovenous fistulas by arteriographic embolization techniques. Arch Surg 1978;113:1153?1159.

  16. Myles RA, Yellin AE: Traumatic injuries of the abdominal aorta. Amer J Surg 1979;138:273?277.

  17. Maher JA, Reynolds TB, Yellin AE: Successful medical treatment of pyogenic liver abscess. Gastroenterology 1979;77:618?622.

  18. Sherwin RP, Richters A, Yellin AE, Donovan AJ: Histoculture of human breast cancers. J Surg Onc 1980;13:9?20.

  19. Trunkey D, Yellin AE, McDonald J, Scott RS: Does Los Angeles County need trauma centers? Stat 1980;1:63?68.

  20. Quatramoni JC, Rosoff L, Halls JM, Yellin AE: Early postoperative small bowel obstruction. Ann Surg 1980;191:72?74.

  21. Fitzgibbons TJ, Green G, Silberman H, Eliasoph J, Halls J, Yellin AE: Management of Crohn's disease involving the duodenum, including duodenal cutaneous fistula. Arch Surg 1980;115:1022?1028.

  22. McNeese S, Finck E, Yellin AE: Definitive treatment of selected vascular injuries and post? traumatic arteriovenous fistulas by arteriographic embolization. Amer J Surg 1980;140:252?259.

  23. Yellin AE: Gastric phototherapy and the argon ion laser: A Review. Surg Ann 1981;13:185?203.

  24. Yellin AE, Donovan AJ: Biliary lithiasis and helminthiasis. Amer J Surg 1981;142:128?136.

  25. Payne J Jr, Yellin AE: Traumatic diaphragmatic hernia. Arch Surg 1982;117:18?24.

  26. Fitzgibbons TJ, Yellin AE, Maruyama M, Donovan AJ: Management of the transected pancreas following distal pancreatectomy. Surg Gynecol Obstet 1982;154:225?231.

  27. Berne TV, Yellin AE, Appleman M, Heseltine P: Antibiotic management of surgically treated gangrenous or perforated appendicitis: A comparison of three regimens. Amer J Surg 1982;144:8?13.

  28. Buchwald H, Moore RB, Matts JP, Long J, Varco RL, Campbell G, Pearce M, Yellin AE, et al: The program on the surgical control of the hyperlipidemias (POSCH). A status report. Surg 1982;92:654-662.

  29. Picone S, Donovan AJ, Yellin AE: Abdominal colectomy for chronic hepatic encephalopathy due to portal?systemic venous shunt. Arch Surg 1983;118:33?37.

  30. Yellin AE: Ascites and the peritoneovenous shunt. West J Med 1983;138:248.

  31. Yellin AE, Lundell C, Finck E: The diagnosis and control of post traumatic pelvic hemorrhage by transcatheter angiographic embolization techniques. Arch Surg 1983;118:1378?1383.

  32. Heseltine PNR, Yellin AE, Appleman MA, Gill MA, Chenella FC, Kern JW, Berne TV: Perforated and gangrenous appendicitis: An analysis of antibiotic failure. J Inf Dis 1983;148:322?329.

  33. Torres MJ, Kern JW, Gill MA, Berne TV, Heseltine PNR, Yellin AE: Comparison of serum sampling strategies for gentamicin. Clin Phar 1983;2:353?355.

  34. Gill MA, Kern JW, Chenella FC, Berne TV, Heseltine PNR, Yellin AE: Influence of manufacture lot number on pharmacokinetic manipulation of gentamicin serum concentrations. Ther Drug Monit 1984;5:419?422.

  35. Gill MA, Cohen JL, Chenella FC, Hisayasu GH, Chandrasoma P, Warnecke GH, Chung H, Heseltine PNR, Yellin AE, Berne TV: Gentamicin penetration into diseased appendix tissue. Ther Drug Mont 1984;6:298?301.

  36. Gill MA, Kern JW, Chenella FC, Yellin AE, Heseltine PNR, Berne TV: Gentamicin dosage adjustment by pharmacists. Hosp Form 1984;19:925?932.

  37. Gill MA, Kern JW, Chenella FC, Heseltine PNR, Yellin AE, Foulds G, Berne TV: Pharmacokinetics of parenteral sulbactam in patients with appendicitis. Ther Drug Monit 1984;6:428?431.

  38. Fisher M, Yellin AE: Bilateral visual loss in carotid artery disease. J Clin Neuroophthal 1985;5:109?111.

  39. Yellin AE, Heseltine PNR, Berne TV, Appleman MD, Gill MA, Riggio CE, Chenella FC: The role of pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet 1985;161:303?307.

  40. Gill MA, Chenella FC, Yellin AE, Heseltine PNR, Berne TV, Appleman MD, Feldman MJ: Antibiotic cost analysis in patients with abdominal stab wounds. Curr Ther Res 1985;38:931?938.

  41. Stiles QA, Cohlmia GS, Smith JH, Dunn JT, Yellin AE: Management of injuries of the thoracic and abdominal aorta. Amer J Surg 1985;150:132?140.

  42. Gill MA, Chenella FC, Heseltine PNR, Appleman MD, Yellin AE, Berne TV, Feldman MJ, Sharon D: Cost analysis of antibiotic therapies used in the management of perforated or gangrenous appendicitis. Amer J Surg 1986;151:200?204.

  43. Heseltine PNR, Berne TV, Yellin AE, Appleman MD: The efficacy of cefoxitin vs. clindamycin? gentamicin in surgically treated stab wounds of the bowel. J Trauma 1986;26:241?245.

  44. Heseltine PNR, Yellin AE, Appleman MD, Gill MA, Chenella FC, Berne TV, Leedom JM: Imipenem therapy for perforated and gangrenous appendicitis. Surg Gynecol Obstet 1986;162:43?48.

  45. Harley HAJ, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JD, Yellin AE: Results of a randomized trial of end?to?side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterol 1986;91:802?809.

  46. Gill MA, Cheetham TC, Chenella FC, Heseltine PNR, Yellin AE, Appleman MD, Berne TV: Matched case?control study of adjusted vs. non?adjusted gentamicin dosing in perforated and gangrenous appendicitis. Ther Drug Monit 1986;8:451?456.

  47. Gill MA, Chenella FC, Heseltine PNR, Yellin AE, Berne TV, Appleman MD, Feldman MJ, Leedom JM: Economic considerations in perforated and gangrenous appendicitis: Imipenem cilastatin vs. clindamycin and gentamicin. Curr Ther Res 1986;40:393?402.

  48. Ahn SA, Yellin AE, Cheng FC, Colonna JO, Goldstein LL, Busuttil RW: Selective surgical therapy of the Budd?Chiari syndrome provides superior survivor rates than conservative medical management. J. Vasc Surg 1987;5:28?37.

  49. Berne TV, Yellin AE, Appleman MD, Gill MA, Chenella FC, Heseltine PNR: Surgically treated gangrenous or perforated appendicitis: A comparison of aztreonam and clindamycin vs. gentamicin and clindamycin. Ann Surg 1987;205:133?137.

  50. Harch JM, Radin RD, Yellin AE, Donovan AJ: Pylethrombosis: Serendipitous radiologic diagnosis. Arch Surg 1987;122:1116?1119.

  51. Gill MA, Chenella FC, Ito MK, Berne TV, Yellin AE, Heseltine PNR, Appleman MD: A cost comparison of clindamycin and aztreonam vs. clindamycin and gentamicin in perforated and gangrenous appendicitis. Curr Ther Res 1987;42:680?689.

  52. Ito MK, Gill MA, Chenella FC, Berne TV, Yellin AE, Heseltine PNR, Appleman MD: Intraoperative serum, bile and gallbladder wall concentrations of cefmetazole in patients undergoing cholecystectomy. Clin Phar 1988;7:467?468.

  53. Wagner WH, Calkins ER, Weaver FA, Goodwin JA, Myles RA, Yellin AE: Blunt popliteal artery trauma: 100 Consecutive cases. J Vasc Surg 1988;7:736?748.

  54. Heseltine PNR, Gill MA, Yellin AE, Appleman MD, Berne TV: Treatment of complicated appendicitis imipenem/cilastatin. Inf Surg 1988;7:537?545.

  55. Weaver FA, Yellin AE, Wagner WH, Brooks SH, Weaver AA, Milford MA: The role of arterial reconstruction in penetrating carotid injuries. Arch Surg 1988;123:1106?1111.

  56. Milford MA, Weaver FA, Lundell CA, Yellin AE: Femoropopliteal percutaneous transluminal angioplasty (PTA) for limb salvage. J Vasc Surg 1988;8:292?299.

  57. Stain SC, Yellin AE, Donovan AJ: Hepatic trauma. Arch Surg 1988;123:1251?1256.

  58. Suda RW, Weaver FA, Stiles GM, Yellin AE: Injuries to the ascending aorta, aortic arch and great vessels. Surg Gynecol Obstet 1989;169:27?31.

  59. Chin A, Gill MA, Ito MK, Berne TV, Yellin, AE, Heseltine PNR, Appleman MD, Chenella FC: Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix. Ther Drug Monit 1989;11:421?424.

  60. Weaver FA, Wagner WH, Yellin AE, Cohen JL: Monocular blindness following penetrating carotid artery trauma. J Vasc Surg 1989;10:89?92.

  61. Blickenstaff KL, Weaver FA, Yellin AE, Stain SC, Finck E: Trends in the management of traumatic vertebral artery injuries. Amer J Surg 1989;158:101?106.

  62. Stain SC, Yellin AE, Weaver FA, Pentecost MJ: Selective management of nonocclusive arterial injuries. Arch Surg 1989;124:1136?1141.

  63. Buchwald H, Matts JP, Fitch LL, Varco RL, Campbell GS, Pearce M, Yellin AE, Smink RD Jr., Sawin HS Jr., Campos CT, Hansen BJ, Long JM and the POSCH Group: Program on the surgical control of the Hyperlipidemias (POSCH): Design and Methodology. J Clin Epidem 1989;42:1111?1127.

  64. Ito MK, Gill MA, Yellin AE, Berne TV, Heseltine PNR, Appleman MD, Leedom JM: The cost effectiveness of sulbactam?ampicillin versus moxalactam in the management of acute cholecystitis. Curr Ther Res 1989;4:747?754.

  65. Chin A, Gill MA, Ito MK, Yellin AE, Berne TVB, Heseltine PNR, Appleman MD: Cost analysis of two clindamycin dosing regimens. DICP, Ann Pharm 1989;23:980?984.

  66. Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: A cost comparison of intramuscular versus intravenous imipenem. Hospital Pharmacy 1989;24:905?909.

  67. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Sawin HS, Campos CT, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda?Zuniga WR, Hunter D, Bissett JK, Weber FJ, Stevensen JW, Leon AS, Hansen BJ, Chalmors TC, and the POSCH Group: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the program on the surgical control of the hyperlipidemias (POSCH). NEJM 1990;323:946?955.

  68. Berne TV, Yellin AE, Appleman MD, Gill MA, Chenella FC, Heseltine PNR: A controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy. Surg Gynecol Obstet 1990;170:137?140.

  69. Goren G, Yellin AE: Primary varicose veins: Topographic and Hemodynamic correlations. J. Cardiovasc Surg 1990;31:672?677.

  70. Applebaum R, Yellin AE, Weaver FA, Oberg J, Pentecost M: The role of routine arteriography in blunt lower extremity trauma. Amer J Surg 1990;160:221?225.

  71. Weaver FA, Yellin AE, Bauer M, Oberg J, Ghalambour N, Emmanuel RP, Applebaum RM, Pentecost MJ, Shorr RM: Is arterial proximity a valid indication for arteriography in penetrating extremity trauma? A prospective analysis. Arch Surg 1990;125:1256?1260.

  72. Weaver FA, Yellin AE, Campen D, Oberg J, Foran J, Kitridou R, Lee S, Kohl RD: Surgical procedures in the management of Takayasu's arteritis. J Vasc Surg 1990;12:429?439.

  73. Treiman GS, Yellin AE, Weaver FA, Barlow W, Treiman RL, Gaspar MR: An effective treatment protocol for intra?arterial drug injection IADI). J Vasc Surg 1990;125:456?466.

  74. Evans GRD, Yellin AE, Weaver FA, Stain SC: Sinistral portal hypertension. Amer Surg 1990;56:758?765.

  75. Okamoto MP, Chin A, Gill MA, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: A comparison of two bayesian microcomputer pharmacokinetic programs in the prediction of serum gentamicin levels. Clinical Pharm 1990;9:708?711.

  76. Bubrick MP, Yellin AE, Heseltine PNR, Cocchetto DM, Heim?Duthoy KL, Berne TV, Appleman MD, Matzke GR: Ceftazidime/clindamycin vs.tobramycin/clindamycin in the treatment of intra? abdominal infections in surgical patients. Amer Surg 1990;56(10):613?617.

  77. Weaver FA, Pentecost MJ, Yellin AE: Carbon dioxide subtraction arteriography: A pilot study. Ann Vasc Surg 1990;4:437?441.

  78. Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: Intra?abdominal Infections: Cost comparison of two treatment regimens. Hospital Formulary 1990;25:295?306.

  79. Chin A, Okamoto MP, Gill MA, Berne TV, Yellin AE, Heseltine PNR, Appleman MD: Intraoperative concentrations of ofloxacin in serum, bile fluid and gallbladder wall tissue. Antimicrob Agents and Chemother 1990;12(34):2354?2357.

  80. Donovan AJ, Yellin AE, Ralls PW: Hepatic abscess. World J Surg 1991;15:162?169.

  81. Stain SC, Weaver FA, Yellin AE: Extra?anatomic bypass of failed traumatic arterial repairs. J Trauma 1991;31:575?578.

  82. Weaver FA, Pentecost MJ, Yellin AE, Davis S, Finck E, Teitelbaum G: Clinical application of carbon dioxide/digital subtraction arteriography. J Vasc Surg 1991;13:266?273.

  83. Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce M, Yellin A, Edmiston WA, Smink RD, Sawin HS, Hansen BJ, Long JM, and the POSCH Group: Program on the Surgical Control of the Hyperlipidemias (POSCH): Patient entry characteristics. Controlled Clin Trials 1991;12:314?339.

  84. Okamoto M, Chin A, Gill MA, Yellin AE, Heseltine PNR, Berne TV, Appleman MD: Analysis of cefepime tissue penetration into the human appendix. Pharmacotherapy 1991;11:353?358.

  85. Yellin AE, Heseltine PNR, Berne TV, Appleman MD, Gill MA, Chenella FC: Intramuscular imipenem as adjuvant therapy for acute cholecystitis and perforated or gangrenous appendicitis. Chemotherapy 1991;37(2):37?43.

  86. Stain SC, Yellin AE, Donovan AJ, Brien HW: Pyogenic liver abscess: Modern treatment. Arch Surg 1991;126:991?996.

  87. Goren G, Yellin AE: Ambulatory stab evulsion phlebectomy for truncal varicose veins. Am J Surg 1991;162:166?174.

  88. Brien HW, Yellin AE, Weaver FA, Carroll BF: A review of carotid endarterectomy at a large teaching hospital. Amer Surg 1991;57:756?762.

  89. Korula J, Yellin AE, Kanel G, Campofiori G, Nichols P: Hepatocellular carcinoma coexisting with hepatic adenoma: Incidental discovery after long term oral contraceptive use. Western J Med 1991;155:416?418.

  90. Korula J, Yellin A, Kanel G, Nichols P: Portal vein thrombosis complicating endoscopic variceal sclerotherapy: Convincing further evidence. Digestive Diseases and Sciences 1991;36:1164?1167.

  91. Okamoto MP, Gill MA, Nakahiro RK, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: Tissue pharmacokinetics of cefepime in patients with acute cholecystitis. Therapeutic Drug Monitoring 1992;14:220?225.

  92. Okamoto MP, Gill MA, Nakahiro RK, Chin A, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: Cost analysis of cefmetazole versus cefoxitin in the treatment of penetrating abdominal trauma. Current Therapeutic Research 1992;52:1?8.

  93. Johnson SB, Weaver FA, Yellin AE, Kelly R, Bauer M: Clinical results of decompressive dermotomy?fasciotomy. Amer J Surg September 1992;164(3):286?290.

  94. Sank A, Rostami K, Weaver FA, Ertl D, Yellin AE, Nimni M, Tuan T?L: New evidence and new hope concerning endothelial seeding of vascular grafts. Amer J Surg, September 1992;164(3):199?204.

  95. Treiman GS, Yellin AE, Weaver FA, Wang S, Ghalambor N, Barlow W, Snyder B, Pentecost MJ: Evaluation of the patient with a knee dislocation: The case for selective arteriography. Arch Surg, September 1992;127:1056?1063.

  96. Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME, Amplatz K, Castaneda?Zuniga WR, Hunter DW, Pearce MB, Bissett JK, Edmiston WA, Sawin HS, Weber FJ, Varco RL, Campbell GS, Yellin AE, Smink RD, Long JM, Hansen BJ, Chalmers TC, Meier P, Stamler J, and the POSCH Group: Changes in sequential coronary arteriograms and subsequent coronary events. JAMA, September 16, 1992;268(11):1429?1433

  97. Buchwald H, Campos CT, Matts JP, Fitch LL, Long JM, Varco RL, and the POSCH Group: Women in the POSCH Trial ? Effects of aggressive cholesterol modification in women with coronary hart disease. Ann Surg, October 1992;389?400.

  98. Wei D, Rostami K, Tuan T?L, Ertl D, Nimni M, Reid J, Weaver FA, Yellin AE, Sank AC: Endothelial cell dysfunction on synthetic bypass grafts corrected by extracellular matrix coatings. American College of Surgeons, Surgical Forum XLIII 1992;324?327.

  99. Reid J, Rostami K, Tuan T?L, Ertl D, Nimni M, Weaver FA, Yellin AE, Wei D, Sank A: Diabetic tissue repair: The role of endothelial cells and basement membrane. American College of Surgeons, Surgical Forum XLIII 1992, 675?677.

  100. Weaver FA and Yellin AE: Surgical treatment of Takayasu arteritis. Heart and Vessels 1992;Suppl.7:154?1 58.

  101. Okamoto MP, Gill MA, Nakahiro RK, Bedikian A, Chin A, Yellin AE, Berne TV: Cefepime pharmacokinetics in patients with acute cholecystitis undergoing cholecystectomy. Clinical Pharmacy 1993;12:134?137.

  102. Schwartz MR, Weaver FA, Yellin AE, Bauer M, Siegel AE: Refining the indications for arteriography in penetrating extremity trauma: a prospective analysis. J Vasc Surg 1993;17(1):116-124.

  103. Yellin AE, Berne TV, Heseltine PNR, Appleman MD, Gill M, Chin A, Baker FJ: Prospective randomized study of two different doses of clindamycin admixed with gentamicin in the management of perforated appendicitis. Amer Surgeon 1993;59(4):248?255.

  104. Okamoto MP, Gill MA, Nakahiro RK, Chin A, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: Cost analysis of cefmetazole versus cefoxitin in the treatment of penetrating abdominal trauma. Current Therapeutic Research 1993;53(2):159.

  105. Schwartz M, Weaver FA, Yellin AE, Ralls P, Siegel AE: The utility of color flow doppler (triplex) examination in penetrating extremity trauma. Amer Surg 1993;59(6):375?378.

  106. Kelly RF, Yellin AE, Weaver FA: Candida thrombosis of the innominate vein with septic pulmonary emboli. Ann Vasc Surg 1993;7(4):343?346.

  107. Berne TV, Yellin AE, Appleman MD, Heseltine PNR, Gill M: A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis. Surg, Gynec & Obstet 1993;177(Supp):18?22.

  108. Yellin AE, Berne TV, Appleman MD, Heseltine PNR, Gill MA, Okamoto MP, Baker FJ, Holcomb C: A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis. Surg, Gynec & Obstet 1993;177(Supp):23?29.

  109. Hood DB, Weaver FA, Modrall JG, Yellin AE: Advances in the treatment of phlegmasia cerulea dolens. Amer J Surg 1993;166:206?210.

  110. Sirinek K, Schauer PR, Yellin AE, Berne TV, Heseltine P, Appleman M, Gill M, Pappa KA: Single?dose cefuroxime as prophylactic therapy for high?risk cholecystectomy. J Am Coll Surg, April 1994;178(4):321?325.

  111. Goren G, Yellin AE: Invaginated axial stripping and stab avulsion (hook) phlebectomy: a definitive outpatient procedure for primary varicose veins. Amb Surg 1994;2:27?35.

  112. Bedikian A, Okamoto MP, Nakahiro RK, Farino J, Heseltine PNR, Appleman MD, Yellin AE, Berne TV, Gill MA: Pharmacokinetics of Meropenem in patients with intra?abdominal infections. Antimicrob Agents and Chemoth 1994;38(1)151?154.

  113. Smith C, Weaver FA, Yellin AE, Li KM, Siegel A: Thrombolytic therapy for arterial occlusion: A mixed blessing? Amer Surg 1994;60:371?375.

  114. Wagner WH, Yellin AE, Weaver FA, Stain SC, Siegel AE: Acute treatment of penetrating popliteal artery trauma: The importance of soft tissue injury. Ann Vas Surg 1994;8(6):557?565.

  115. Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Struve SN, Weigelt JA, Stanford GG, Herr DL, Champion HR, Lewis FR, Hoyt D, Hansbrough J, Yellin AE, Berne TV, Trunkey DO, et al: Effect of interferon gamma on infection?related death in patients with severe injuries: A randomized, double?blind placebo?controlled trial. Arch Surg 1994;129:1041?1031.

  116. Katz, SG, Kohl RD, Yellin AE: lilac angioplasty as a prelude to distal arterial bypass. J Am Coll Surg 1994;179(5):577?582.

  117. Goren G, Yellin AE: Invaginated axial saphenectomy by a semi?rigid stripper: PIN stripping. J Vasc Surg 1994;20:970?977.

  118. Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver FA, Yellin AE, Tuan T?L: Human endothelial cells are defective in diabetic vascular disease. J Surg Research 1994;54:647?653.

  119. Hood DB, Yellin AE, Richman MF, Weaver, FA, Katz MD: Hemodialysis graft salvage with endoluminal stents. Amer Surg 1994;60:733?743.

  120. Ortega A, Yellin AE, Weaver FA: Blunt traumatic injuries of the internal carotid artery. Contemporary Surgery 1995;46:26?29.

  121. Stain SC, Incarbone R, Guthrie CR, Ralls PW, Rivera?Lara S, Parekh D, Yellin AE: Surgical treatment of recurrent pyogenic cholangitis. Arch Surg 1995;130(5):527?533.

  122. Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE, Smink RD, Sawin HS, Long JM: Subgroup analyses of the major clinical endpoints in the program on the surgical control of the hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction. J Clin Epidem 1995;48(3):389?405.

  123. Stain SC, Guthrie CR, Yellin AE, Donovan AJ: Choledochal cyst in the adult. Ann Surg 1995;222(2):128?133.

  124. Kelly R, Weaver FA, Skinner D, Yellin AE: En bloc resection for bulky metastatic germ cell tumors. J Urology 1995;153:1849?1851.

  125. Demetriades D, Theodorou D, Cornwell E, Weaver F, Yellin A, Velmahos G, Berne TV: Penetrating Injuries of the neck in stable patients: Physical examination, angiography, or Color Flow Doppler. Arch Surg, Sept 1995;130:971?975.

  126. Modrall JG, Weaver FA, Yellin AE: Diagnosis of vascular trauma. Ann Vasc 1995;9(4):415?421.

  127. Goren G, Yellin AE: Minimally invasive surgery for primary varicose veins: Limited invaginated axial stripping and tributary (Hook) stab avulsion. Ann Vas Surg 1995;9(4):401?414.

  128. Ginsberg DA, Modrall JG, Esrig D, Baek S, Yellin AE, Lieskovsky G, Skinner DG, Weaver FA: Concurrent abdominal aortic aneurysm and urologic neoplasm: an argument for simultaneous intervention. Ann Vasc Surg 1995;9(5):428?433.

  129. Frankhouse JH, Ryan MG, Papanicolaou G, Yellin AE, Weaver FA: Carbon dioxide/digital subtraction arteriography?assisted transluminal angioplasty. Ann Vasc Surg 1995;9(5)448?452.

  130. Kern JW, Jhee SS, Gill MA, Yellin AE: Piperacillin?tazobactam pharmacokinetics in patients with intra?abdominal infections. Pharmacotherapy 1995;15:472?478.

  131. Jhee SS, Gill MA, Yellin AE, Berne TV, Heseltine PNR, Appleman MD: Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of intra?abdominal infections. Clinical Therap 1995;17:126?135.

  132. Jhee SS, Kern JW, Burm JP, Yellin AE, Gill MA: Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections. Pharmacotherapy 1995;15(4):472-8.

  133. Weaver FA, Modrall G, Baek S, Harvey F, Siegel A, Yellin AE, Rosental J: The role of syme's amputation in patients with severe lower extremity arterial occlusive disease. CV Surg 1996;4:81?86.

  134. Schreier DZ, Weaver FA, Frankhouse J, Papanicolaou G, Shore E, Yellin AE, Harvey F: A prospective study of carbon dioxide digital subtraction vs. standard contrast arteriography in the evaluation of the renal arteries. Arch Surg 1996;131(5):503?508.

  135. Demetriades D, Theodorou D, Asensio J, Golshani S, Belzberg H, Yellin AE, Weaver FA, Berne TV: Management options in vertebral artery injuries. The British J Surg 1996;83:83?86.

  136. Berne TV, Appleman MD, Heseltine PNR, Yellin AE, Gill MA: Meropenem versus Tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis. JACS 1996;182:403?407.

  137. Hood DB, Weaver FA, Papanicolaou G, Wadwhwani A, Yellin AE: Cardiac evaluation of the diabetic patient prior to peripheral vascular surgery. Ann Vasc Surg 1996;10(4):330-335.

  138. Papanicolaou G, Aziz I, Yellin AE, Weaver FA: Intraoperative color duplex for infrainguinal vein grafts. Ann Vasc Surg 1996;10(4):347-355.

  139. Papanicolaou G, Toms C, Yellin AE, Weaver FA: Relationship between intraoperative color flow duplex findings and early restenosis after carotid endarterectomy: A preliminary report. J Vasc Surg 1996;24:588-596.

  140. Kuehne JP, Weaver FA, Papanicolaou G, Yellin AE: Penetrating trauma of the internal carotid artery. Arch Surg 1996;131:942-948.

  141. Ginsberg DA, Esrig D, Grossfeld GD, Stein JP, Freeman JA, Yellin AE, Lieskovsky G, Weaver FA, Skinner DG: Technique of radical cystectomy and simultaneous repair of an abdominal aortic aneurysm. Urology 1996;47(1):120-122.

  142. Demetriades D, Theodorou D, Cornwell E, Berne TV, Asensio J, Belzberg H, Velmahos G, Weaver FA, Yellin AE: Evaluation of penetrating injuries of the neck: prospective study of 223 patients. World J Surg 1997;21:41-48.

  143. Hood DB, Kuehne J, Yellin AE, Weaver FA: Vascular complications of thoracic outlet syndrome. American Surgeon 1997;63(10):913-917.

  144. Modrall J Gregory, Weaver FA, Yellin AE: Diagnosis and management of penetrating vascular trauma and the injured extremity. Em Med Clin of No Am 1998;16:129-144.

  145. Buchwald H, Varco RL, Campos CT, Boen JRB, Williams SE, Hansen BJ, Campbell GS, Pearce MB, Yellin AE, Edmiston A, Smink RD, Sawin HS and the POSCH Group: Effective lipid modification by partial ileal bypass reduced-long term coronary heart disease mortality and morbidity: Five-year posttrial follow-up report from the program on the surgical control of the hyperlipidemias (POSCH). Arch of Int Med 1998;158:1253-1261.

  146. Terramani TT, Roe VL, Hood DB, Eton D, Nuno IN, Yu H, Yellin AE, Starnes VA, Weaver FA: Combined carotid endarterectomy and coronary artery bypass grafting in asymptomatic carotid artery stenosis. The Am Surg 1998;64(10):993-997.

  147. Hood DB, Weaver FA, Yellin AE: Changing perspectives in the diagnosis of peripheral vascular trauma. Sem Vasc Surg 1998;11(4):255-260.

  148. Donahue PE, Smith DL, Lackland AFB, Yellin AE, Mintz SJ, Bur Francois, Luke DR, and The Trovafloxacin Surgical Group: Trovafloxacin in the treatment of intra-abdominal infections: Results of a double-blind, multi-center comparison with imipenem/cilastin. The Am J Surg 1998(Dec);176(6A):53S-61S.

  149. Milsom JW, Smith DL, Lackland AFB, Corman ML, Howerton RA, Yellin AE, Luke DR, and the Trovafloxacin Surgical Group: Double-Blind Comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. The Am J Surg 1998(Dec);176(6A):46S-52S.

  150. Kuehne J, Frankhouse J, Modrall G, Golshani S, Aziz I, Demetriades D, Yellin AE: Determinants of survival after inferior vena cava trauma. The American Surgeon 1999;65:976-981.

  151. Cohn SM, Lipsitt PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, Yellin AE, Jungerwirth S, Rochefort EV, Haverstock DC, Kowalsky SF and the Intra-abdominal Study Group: A Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intra-abdominal infections. Annals of Surgery 2000;232(2):254-262.

  152. Appleman MD, Belzberg H, Citron DM, Heseltine PNR, Yellin AE, Murray J, Berne TV: In vitro activities of nontraditional antimicrobials against multiresistant acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrobial Agents and Chemotherapy 2000;44:(4):1035-1040.

  153. Hood DB, Hua HT, Jensen CC, Yellin AE, Weaver FA: Carbon dioxide digital subtraction and angiography: Is it safe? (In Press) Journal Vascular Surgery.

  154. Treiman GS, Copland S, McNamara RM, Yellin AE, Schneider PA, Treiman RL: Factors influencing ulcer healing in patients with combined arterial and venous insufficiency. J Vasc Surg 2001;33(6):1158-1164.

  155. Treiman GS, Copland S, Yellin AE, Lawrence PF, McNamara RM, Treiman RL: Wound infections involving infrainguinal autogenous vein grafts: A current evaluation of factors determining successful graft preservation. J Vasc Surg 2001;33(5):948-954.






Vascular Home Page 
 Areas of Expertise 
Minimally Invasive and
Endovascular Therapies
 
Abdominal Aortic Aneurysm 
Stroke and
Carotid Artery Disease
 
Leg Pain and Lower Extremity
Arterial Disease
 
Varicose Veins and
Venous Disease
 
Hypertension and
Renal Artery Disease
 
Vascular Access 
 Patient Guide 
Forms and Downloads 
Billing & Reimbursement 
Patient Stories 
Glossary of Terms 
 Programs & Services 
Education 
Clinical Programs 
Clinical Research 
Vascular Nursing 
Support Services 
 General Information 
Faculty & Staff 
Hospitals & Offices 
Web Links 
Calendar of Events 
Site Map 
Contact Us 

Search this site

Copyright © USC Center for Vascular Care
1510 San Pablo Street, Suite 514, Los Angeles CA 90033-4612
Phone: (323) 442-5932     Fax: (323) 442-5735
E-mail: vascular@surgery.usc.edu

University of Southern California